LG Chem Ltd. has won a contract to exclusively supply 30,000 of its key filter membrane product, reverse osmosis (RO) membranes, for a large-scale water desalination project in Israel.
The joint desalination plant is led by two Israeli companies, Shapir Engineering and Industry and Global Environmental Solutions Ltd., currently under construction in the city of Ashdod.
An RO membrane is made with a polymer that filters the seawater down to the molecular level.
LG Chem’s RO membranes tout 99.89 percent salt removal with its unique thin film nanocomposite technology.
The latest RO membrane supply will be able to process 100 million tons of seawater into drinkable water annually, an amount that can be used by about 1.1 million people.
Once the Ashdod plant goes into operation in 2024, it will treat approximately 300 million tons of seawater using LG Chem’s RO membranes, accounting for more than one-third of the amount of water Israel uses daily.


Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



